ICD-10 Code Z11.3: How OB/GYN Practices Bill STI Screening Without Denials

Quick Answers 

Is Z11.3 billable?
Yes, it is HIPAA-valid and can stand as the first-listed diagnosis, but only on a true screening visit for an asymptomatic patient. The moment a symptom is documented, the visit is diagnostic and needs a symptom or condition code instead.

What codes does it get confused with?
HIV screening belongs under Z11.4 and HPV screening under Z11.51, so neither should be reported as Z11.3. Testing driven by a known or suspected exposure uses Z20.2, since exposure is not routine screening.

How do you bill it cleanly?
Link Z11.3 to each screening lab’s own CPT code for medical necessity, add modifier 33 to waive cost-sharing on qualifying preventive lines, and during pregnancy keep routine screening inside the global obstetric package rather than billing it separately.

What Is ICD-10 Code Z11.3?

ICD-10 code Z11.3 is a diagnosis code that reports an encounter for screening for infections with a predominantly sexual mode of transmission, such as routine syphilis, gonorrhea, and chlamydia screening in an asymptomatic patient. It is a valid, HIPAA-compliant code that can stand as the first-listed diagnosis on a true screening visit, but it applies only when the patient has no related symptoms.

• It is billable, but screening only: Z11.3 is valid for HIPAA transactions and can be the first-listed diagnosis, but only for asymptomatic screening, not a symptomatic visit.
• It excludes HIV and HPV: HIV screening is Z11.4 and HPV screening is Z11.51, so reporting either one under Z11.3 is a fast path to denial.
• Exposure is a different code: Testing after a known or suspected exposure uses Z20.2, not Z11.3, because exposure is not routine screening.

New to OB/GYN screening codes? Start with our OB/GYN medical billing overview, then use this page as your deep dive on Z11.3. ICD-10 code Z11.3 looks simple until a clean claim comes back denied. It is valid for billing, but the rules on when it applies, what it excludes, and how it pairs with the visit decide whether you get paid on the first pass.

What ICD-10 Code Z11.3 Covers, and What It Does Not

Z11.3 reports an encounter where the patient has no symptoms and is being screened for sexually transmitted infections. The official ICD-10-CM FY2026 descriptor is “Encounter for screening for infections with a predominantly sexual mode of transmission,” and it covers routine syphilis, gonorrhea, and chlamydia screening for an asymptomatic patient. The word that controls everything is screening. This is a preventive code, not a diagnostic one.

That single distinction is where most denials start. If the patient presents with discharge, pelvic pain, a lesion, or any other complaint, you are no longer screening. You are evaluating a symptom, and the encounter should carry the symptom or condition code rather than Z11.3. Payers reject screening codes attached to symptomatic visits because the documentation contradicts the code, and an automated edit catches the mismatch before a human ever sees it.

Z11.3 is a billable, HIPAA-valid code, so it can stand as the first-listed diagnosis on a genuine screening encounter. The three-character parent, Z11, is only a category header and is never billable on its own. The most common issue we see OB/GYN practices run into with Z11.3 is a screening code sitting in a chart that also documents a symptom, which quietly guarantees a denial no matter how routine the screen was. Getting the screening-versus-symptom call right at the point of documentation is what keeps these encounters out of the rework queue.

The Three Codes Billers Confuse With Z11.3

This is the highest-value point in the entire workflow, because using the wrong sibling code is the fastest route to a rejection. Z11.3 does not cover every sexually transmitted infection, and two of the most common OB/GYN screens live under separate codes. A third trap is the exposure scenario, which is not screening at all.

Code	What It Reports (ICD-10-CM FY2026)	When to Use It
Z11.3	Screening for infections with a predominantly sexual mode of transmission	Asymptomatic patient, routine syphilis, gonorrhea, or chlamydia screening
Z11.4	Screening for human immunodeficiency virus [HIV]	Asymptomatic HIV screening, reported instead of Z11.3
Z11.51	Screening for human papillomavirus (HPV)	Asymptomatic HPV screening, which has its own frequency and coverage rules
Z20.2	Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission	Testing prompted by a known or suspected exposure, not routine screening

Reporting an HIV screen under Z11.3 misrepresents the service and can trip both medical-necessity edits and preventive-benefit logic, and HPV gets its own code because its guidelines and coverage differ from the bacterial STIs. Screening and exposure are also two different clinical stories, and payers treat them differently. Across the billing companies we match providers with, the OB/GYN billers with the cleanest first-pass rates treat these four codes as a pre-submission checklist rather than a lookup they do after a denial. Sorting Z11.3, Z11.4, Z11.51, and Z20.2 correctly resolves the majority of STI screening denials before they ever happen.

Screening vs Diagnostic: The Distinction That Drives Denials

A screening encounter has one defining feature: the patient is asymptomatic, and the test is done to find disease before symptoms appear. That is the only situation in which Z11.3 belongs on the claim. The moment a sign or symptom enters the chart, the logic flips and the visit becomes diagnostic.

A patient who comes in for an STI test because of abnormal discharge is a diagnostic visit, and the discharge or related condition becomes the reason for the encounter. Coding that visit as a screening encounter creates a mismatch between the documentation and the claim, and that mismatch is exactly what an automated payer edit is built to catch. The fix lives in the documentation, not the code lookup. The note should make the screening intent unmistakable: asymptomatic patient, routine screening, no current complaint.

Clinical scenario	Correct code	Why
Asymptomatic routine STI screen	Z11.3	Preventive screening with no symptoms present
Asymptomatic HIV or HPV screen	Z11.4 or Z11.51	Separate screening codes with their own coverage rules
Known or suspected exposure	Z20.2	Exposure testing is not routine screening
Symptomatic visit (discharge, pain, lesion)	Symptom or condition code	The visit is diagnostic, so a Z screening code does not apply

When the chart says screening and the claim says Z11.3, the two agree and the claim moves. When they disagree, the edit wins.

How to Bill Z11.3 in an OB/GYN Practice

Z11.3 is the diagnosis code, not the service. The actual lab tests carry their own CPT codes, such as 86592 for a non-treponemal syphilis screen, 87491 for chlamydia, and 87591 for gonorrhea, and each lab line needs Z11.3 attached as the medical-necessity link. A screening lab order without a screening diagnosis is an incomplete claim. A clean Z11.3 claim comes together in a predictable order:

1. Confirm the patient is asymptomatic and the encounter is documented as routine screening.
2. Assign Z11.3 as the first-listed diagnosis for the screening intent.
3. Report each screening lab with its own CPT code and link Z11.3 as the medical-necessity diagnosis.
4. Append modifier 33 to any line that qualifies as a preventive service so cost-sharing is waived.
5. Check payer frequency limits and pregnancy context before the claim goes out.

Coverage is the next layer. Many STI screenings recommended by the USPSTF for asymptomatic patients are covered as preventive services without patient cost-sharing under the Affordable Care Act. To signal that a service is preventive and that cost-sharing should be waived, billers append modifier 33 to the appropriate line. Skipping modifier 33 on a qualifying preventive screen is a quiet revenue leak, because the patient may be charged for a service that should have been covered in full. If your practice also handles imaging on the same patients, the same medical-necessity discipline applies, and our breakdown of CPT 76830 covers the transvaginal ultrasound rules that commonly travel with these visits. Our summarized OB/GYN Red Book guide is a useful reference for keeping diagnosis selection current across the practice.

How Is Z11.3 Handled During Pregnancy?

During pregnancy, routine STI screening is usually folded into the prenatal care context rather than reported as a stand-alone Z11.3 encounter. The syphilis screen that is standard in pregnancy generally belongs to prenatal supervision, so pulling it out and billing it separately can collide with the global obstetric package and trigger a bundling denial.

This is the trap that catches practices which code Z11.3 correctly in every other setting. The obstetric global package bundles routine prenatal services, and a separately reported screening code can read to the payer as double billing for work already inside the package. In our experience matching providers with billing partners, the prenatal bundling issue surprises newer OB/GYN coders more than any other Z11.3 mistake, precisely because the code itself is valid. If you are coding screening during a pregnancy, confirm whether it belongs to the prenatal supervision context before you reach for Z11.3, and document any screen that is genuinely separate from routine prenatal care so the distinction is defensible on review.

Common Z11.3 Denials and How to Prevent Them

Most Z11.3 denials trace back to a short list of avoidable causes, and each one has a clean fix at the point of coding.

• Symptom paired with a screening code: when a complaint appears in the chart, code the symptom or condition, not the screen.
• HIV or HPV reported under Z11.3: use Z11.4 for HIV screening and Z11.51 for HPV screening instead.
• Exposure coded as routine screening: use Z20.2 when the test is driven by a known or suspected exposure.
• Missing modifier 33: add it to a qualifying preventive line so the patient is not charged cost-sharing that should be waived.
• Prenatal screening billed separately: keep routine prenatal STI screening inside the global obstetric package unless it is genuinely distinct.
• Frequency limits exceeded: confirm how often each payer reimburses a given screen before submitting a repeat claim.

The pattern across all of these is the same. Z11.3 fails when the code, the documentation, and the payer’s coverage rules are not telling one consistent story. Providers often come to us after a run of screening denials they could not explain, and the cause is almost always one of these six, repeated quietly across a full panel of patients. A billing team that knows the OB/GYN payer landscape catches them before submission instead of after a denial.

Frequently Asked Questions